東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Association Between Sex, Cachexia Status, and Muscle Wasting in Pancreatic Cancer : = A Retrospective Study.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Association Between Sex, Cachexia Status, and Muscle Wasting in Pancreatic Cancer :/
其他題名:	A Retrospective Study.
作者:	Freeman, Ashley.
面頁冊數:	1 online resource (50 pages)
附註:	Source: Masters Abstracts International, Volume: 85-01.
Contained By:	Masters Abstracts International85-01.
標題:	Health sciences. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30425772click for full text (PQDT)
ISBN:	9798379786557

Association Between Sex, Cachexia Status, and Muscle Wasting in Pancreatic Cancer : = A Retrospective Study.
Freeman, Ashley.

Association Between Sex, Cachexia Status, and Muscle Wasting in Pancreatic Cancer :A Retrospective Study. - 1 online resource (50 pages)

Source: Masters Abstracts International, Volume: 85-01.

Thesis (M.S.)--The University of Iowa, 2023.

Includes bibliographical references

Background: Cachexia is a complex metabolic disease consisting of progressive and unintentional weight loss from the depletion of skeletal muscle and adipose tissue. Cancer cachexia is formally defined through consensus definition as a weight loss of greater than 5% in six months. In pancreatic ductal adenocarcinoma (PDAC), up to 80% of patients have cachexia at the time of their diagnosis. Cachexia is associated with several negative outcomes, including reduced survival, greater treatment toxicity, worse post-surgical outcomes, and lower quality of life due to progressive functional impairment. Emerging evidence suggests sex is a critical variable in the pathophysiology of cancer cachexia. Objective: To investigate the sex difference in body composition in patients with PDAC and, subsequently, advance how cachexia clinical trials and therapeutics are used clinically. Methods: Body composition was assessed on CT images of PDAC patients taken during routine care. Total cross-sectional area of skeletal muscle (SKM), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) were assessed at the third lumbar vertebrae. Clinical data were extracted from patient medical records. Survival data were analyzed for 192 PDAC patients. To understand differences in body composition at the time of diagnosis, scans closest to diagnosis were analyzed for the 176 treatment-naive patients. Results: 72% of patients had cachexia at the time of diagnosis. Mean weight loss in cachectic patients at the time of diagnosis was 13.19%, compared to the mean weight loss of 1.84% in noncachectic patients. Cachectic males had lower SKM indices at the time of diagnosis compared to their non-cachectic counterparts (83.78 ± 14.15 cm2 /m cachectic vs. 90.39 ± 14.90 cm2 /m noncachectic, p=0.047), but females had no such association (69.76 ±10.60 cm2 /m cachectic vs. 70.07 ± 10.59 cm2 /m non-cachectic, p=0.90). Cachectic females had lower SAT indices at the time of diagnosis (75.09 ± 36.18 cm2 /m cachectic vs. 57.36 ± 30.77 cm2 /m non-cachectic, p=0.03), but no such differences were seen between cachectic and non-cachectic males (19.27 ± 8.71 cm2 /m vs. 23.03 ± 10.20 cm2 /m, respectively, p=0.08). Consistent with published data, patients with cachexia had significantly shorter median survival than those without cachexia (1.96 years non-cachectic vs. 1.46 years cachectic, p=0.009). Separate analyses revealed that a BMI-adjusted weight loss grading system referred to as cachexia grade significantly associated with survival in males (1.93 years low-grade vs. 1.56 years high-grade, p=0.001) but not females (1.36 years low-grade vs. 1.40 years high-grade, p=0.58). These sex differences remained after adjustment for age and metastatic disease. Conclusions: Our data show distinct differences in the phenotype of males and females with pancreatic cancer-induced cachexia and necessitates exploration of sex-specific anti-cachexia therapeutic interventions.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798379786557Subjects--Topical Terms:

3168359
Health sciences.
Subjects--Index Terms:

CachexiaIndex Terms--Genre/Form:

542853
Electronic books.

Association Between Sex, Cachexia Status, and Muscle Wasting in Pancreatic Cancer : = A Retrospective Study.
LDR:04313nmm a2200385K 4500 001 2360275
005 20230926101829.5
006 m o d
007 cr mn ---uuuuu
008 241011s2023 xx obm 000 0 eng d
020 $a 9798379786557
035 $a (MiAaPQ)AAI30425772
035 $a AAI30425772
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Freeman, Ashley. $3 3700891
245 1 0 $a Association Between Sex, Cachexia Status, and Muscle Wasting in Pancreatic Cancer : $b A Retrospective Study.
264 0 $c 2023
300 $a 1 online resource (50 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 85-01.
500 $a Advisor: Talbert, Erin.
502 $a Thesis (M.S.)--The University of Iowa, 2023.
504 $a Includes bibliographical references
520 $a Background: Cachexia is a complex metabolic disease consisting of progressive and unintentional weight loss from the depletion of skeletal muscle and adipose tissue. Cancer cachexia is formally defined through consensus definition as a weight loss of greater than 5% in six months. In pancreatic ductal adenocarcinoma (PDAC), up to 80% of patients have cachexia at the time of their diagnosis. Cachexia is associated with several negative outcomes, including reduced survival, greater treatment toxicity, worse post-surgical outcomes, and lower quality of life due to progressive functional impairment. Emerging evidence suggests sex is a critical variable in the pathophysiology of cancer cachexia. Objective: To investigate the sex difference in body composition in patients with PDAC and, subsequently, advance how cachexia clinical trials and therapeutics are used clinically. Methods: Body composition was assessed on CT images of PDAC patients taken during routine care. Total cross-sectional area of skeletal muscle (SKM), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) were assessed at the third lumbar vertebrae. Clinical data were extracted from patient medical records. Survival data were analyzed for 192 PDAC patients. To understand differences in body composition at the time of diagnosis, scans closest to diagnosis were analyzed for the 176 treatment-naive patients. Results: 72% of patients had cachexia at the time of diagnosis. Mean weight loss in cachectic patients at the time of diagnosis was 13.19%, compared to the mean weight loss of 1.84% in noncachectic patients. Cachectic males had lower SKM indices at the time of diagnosis compared to their non-cachectic counterparts (83.78 ± 14.15 cm2 /m cachectic vs. 90.39 ± 14.90 cm2 /m noncachectic, p=0.047), but females had no such association (69.76 ±10.60 cm2 /m cachectic vs. 70.07 ± 10.59 cm2 /m non-cachectic, p=0.90). Cachectic females had lower SAT indices at the time of diagnosis (75.09 ± 36.18 cm2 /m cachectic vs. 57.36 ± 30.77 cm2 /m non-cachectic, p=0.03), but no such differences were seen between cachectic and non-cachectic males (19.27 ± 8.71 cm2 /m vs. 23.03 ± 10.20 cm2 /m, respectively, p=0.08). Consistent with published data, patients with cachexia had significantly shorter median survival than those without cachexia (1.96 years non-cachectic vs. 1.46 years cachectic, p=0.009). Separate analyses revealed that a BMI-adjusted weight loss grading system referred to as cachexia grade significantly associated with survival in males (1.93 years low-grade vs. 1.56 years high-grade, p=0.001) but not females (1.36 years low-grade vs. 1.40 years high-grade, p=0.58). These sex differences remained after adjustment for age and metastatic disease. Conclusions: Our data show distinct differences in the phenotype of males and females with pancreatic cancer-induced cachexia and necessitates exploration of sex-specific anti-cachexia therapeutic interventions.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Health sciences. $3 3168359
650 4 $a Oncology. $3 751006
653 $a Cachexia
653 $a Cancer
653 $a Pancreatic cancer
653 $a Skeletal muscle
653 $a Weight loss
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0566
690 $a 0992
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a The University of Iowa. $b Health and Human Physiology. $3 3557043
773 0 $t Masters Abstracts International $g 85-01.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30425772 $z click for full text (PQDT)